RecruitingPHASE1, PHASE2NCT07251491

Psilocybin to Treat Depression in Spinal Cord Injury

Studying Neuromuscular disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
James J. Peters Veterans Affairs Medical Center
Principal Investigator
Jill M Wecht, EdD
James J Peters VA Medical Center
Intervention
Psilocybin (Usona Institute)(drug)
Enrollment
30 target
Eligibility
22 years · All sexes
Timeline
20262028

Study locations (1)

Collaborators

Bronx Veterans Medical Research Foundation, Inc · Usona Institute · United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07251491 on ClinicalTrials.gov

Other trials for Neuromuscular disease

Additional recruiting or active studies for the same condition.

See all trials for Neuromuscular disease

← Back to all trials